The novel omega-3 technology is designed to accelerate the nutrient’s absorption and ensure its delivery to the sites where the body most needs it.
Photo © Shutterstock.com/1989studio
Amidst a growing market for omega-3 supplements-but a market in which omega-3 deficiency remains a global health issue-BASF Newtrition Omega-3 (Oslo, Norway) has introduced Accelon, a novel omega-3 technology designed to accelerate the nutrient’s absorption and ensure its delivery to the sites where the body most needs it.
The technology works by allowing the omega-3 to disperse quickly into a micro-emulsion upon entering the stomach. This micro-emulsion then passes into the intestinal lumen, where the extensive and easily accessed surface area of the micro-droplets makes for more effective digestion and enhanced release of EPA and DHA omega-3s in the free fatty acid form. According to a company statement, this means that significantly more EPA and DHA can diffuse and be absorbed through the mucosal cells and thus enter into circulation.
The company noted that studies have quantified a minimum fourfold improvement in omega-3 absorption relative to other high-concentrate omega-3 products-even on an empty stomach-courtesy of the new technology. Given that many consumers don’t take omega-3 supplements with food-despite advice to do so-the high rates of fasting absorption are impressive and could increase ease of use and compliance.
And for those consumers who do take the new ingredient with food, it still yields a rate of absorption 30% greater than what other omega-3 supplements achieve, the company statement noted, representing “a significant, distinct and relevant breakthrough for the omega-3 supplements category.”
Consumer research shows that supplement users “liked the idea of a turbo-charged, effectively absorbed ‘intelligent’ omega-3 which reaches the body’s cells where it’s needed, without having to take it with food or at a specific time of days,” said Ãyvind Ihle, team leader at Newtrition Omega-3, in the press statement. “In fact, new product concepts featuring the Accelon logo on pack clearly resonated with consumers as they scored 30% higher on purchase intent than those without.”
Brand owners, he added, would be wise to take advantage of that edge. “People need simple and credible reasons to believe that it’s worthwhile taking omega-3 supplements regularly. This is what’s going to help brand owners build the category and we look forward to meeting them to discuss together how we can support their growth ambitions.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.